Michigan’s CytoPherx gets $2M investment for anti-inflammation devices

The Ann Arbor-based company is developing devices that treat renal disease and inflammation caused by cardiopulmonary bypass surgery.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics